Cite
HARVARD Citation
Petrak, R. et al. (2021). Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2. Clinical and translational science. 14 (6), pp. 2146-2151. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Petrak, R. et al. (2021). Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2. Clinical and translational science. 14 (6), pp. 2146-2151. [Online].